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Abstract
For more than a century, clinical investigators have focused on early life as a source of adult
psychopathology. Early theories about psychic conflict and toxic parenting have been replaced by
more recent formulations of complex interactions of genes and environment. Although the
hypothesized mechanisms have evolved, a central notion remains: early life is a period of unique
sensitivity during which experience confers enduring effects. The mechanisms for these effects
remain almost as much a mystery today as they were a century ago. Recent studies suggest that
maternal diet can program offspring growth and metabolic pathways, altering lifelong
susceptibility to diabetes and obesity. If maternal psychosocial experience has similar
programming effects on the developing offspring, one might expect a comparable contribution to
neurodevelopmental disorders, including affective disorders, schizophrenia, autism, and eating
disorders. Due to their early onset, prevalence, and chronicity, some of these disorders, such as
depression and schizophrenia, are among the highest causes of disability worldwide according to
the World Health Organization 2002 report. Consideration of the early life programming and
transcriptional regulation in adult exposures supports a critical need to understand epigenetic
mechanisms as a critical determinant in disease predisposition. Incorporating the latest insight
gained from clinical and epidemiological studies with potential epigenetic mechanisms from basic
research, the following review summarizes findings from a workshop on Early Life Programming
and Neurodevelopmental Disorders held at the University of Pennsylvania in 2009.
Historically, the term epigenetics has referred to heritable traits that are not mediated by
changes in DNA sequence. More recently, epigenetics has been used more broadly to refer
to any change in gene function not associated with sequence variation (1,2) and has been
embraced by the neuroscience community as a means by which we can integrate a role for
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the environment to influence or “program” gene expression or patterns that may or may not
be heritable (3–5). Epigenetic mechanisms typically involve DNA methylation, histone
acetylation, and noncoding RNAs, including microRNAs. Increasing evidence shows that
numerous types of chromatin modifications, referred to as chromatin remodeling, are
widespread in the brain and undergo dynamic regulation in both the developing and adult
nervous system (6). Incorporating the latest insight gained from clinical and epidemiological
studies with potential epigenetic mechanisms from basic research, the following report
summarizes findings discussed at a recent conference on Early Life Programming and
Neurodevelopmental Disorders held at the University of Pennsylvania. The conference was
thematically based on identifying common mechanisms that may underlie
neurodevelopmental disease predisposition and included prenatal, postnatal, and early
developmental determinants such as stress experience and maternal diet, behavior, and
infection. The goal of the conference and this report is to disseminate the most recent
findings across epidemiological, clinical, and basic science in early life programming to
inform new directions and needs in the field. These findings are discussed below subdivided
into areas of disease focus.
Fetal Antecedents and Programming in Neurodevelopmental Disorders
Schizophrenia
Prenatal and early life events have been associated with the development of schizophrenia.
In support of a temporal specificity to the effects of stress on long-term outcome in
neurodevelopmental disorders, a recent epidemiological study reported a significant
association between maternal stress experienced during the first trimester of pregnancy with
an increased risk of schizophrenia in male offspring (7). Prospective birth cohort studies
have suggested that such stress exposures act by altering brain development and possibly
influencing fetal brain growth through epigenetic modifications. Studies from large birth
cohorts in which clinical, neurocognitive, and neuroimaging measures have been obtained
have revealed associations between in utero exposure to infections, hypoxia, starvation, and
other prenatal risk factors and risk for schizophrenia (8–14), including disturbances of
executive function, working memory, verbal memory, and structural brain abnormalities
among offspring with schizophrenia (11,15). Neuroimaging findings indicated that prenatal
infection was related to enlargement of the cavum septum pellucidum and diminished
intracranial volume in these cases (16). Sex also appears to be a strong determinant in
schizophrenia risk where neurodevelopmental changes in the hypothalamus and arousal
circuitry have been shown to be gender-specific (17,18).
Affective Disorders
There is growing evidence supporting an association between fetal risk factors and affective
disorders. Birth cohort studies have identified prenatal conditions, including maternal
immune and stress responses, as significant risk factors for major depressive disorder
(MDD) (19,20). Second trimester maternal exposure to type A2/Singapore influenza
significantly increased the risk for unipolar and bipolar disorders in Finnish and British
cohorts of adults (21–23). Maternal exposure to famine during the second and third
trimesters elevated risk for MDD, supporting again an important link between maternal
nutrition and offspring neurodevelopment (24,25). Although maternal infection, stress, and
undernutrition differentially impact the developing fetus, there may be shared underlying
mechanisms contributing to an increased vulnerability to MDD, including effects on
hypothalamic-pituitary-adrenal (HPA) axis programming (26).
As the brain continues to mature and develop well into adolescence, it is also critical to
understand the influence of the postnatal environment on programming of disease risk. In
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the past decade, remarkable progress has been made in studies of the long-term
consequences of adverse early childhood experience. Analyses of an extensive database
have unequivocally revealed that adults exposed to child abuse and/or neglect are at greater
risk for the development of affective disorders (27). Therefore, investigators have sought to
determine the neurobiological mechanisms that mediate these outcomes in clinical studies
and in laboratory animal models. In nonhuman primates and clinical studies, there is clear
evidence for long-term neurobiological, neuroendocrine, and immune alterations after
exposure to early adverse events during critical periods in development (recent summaries
are available [28,29]). Plasma adrenocorticotropic hormone and cortisol responses to
relatively mild stressors are markedly increased in humans that have experienced childhood
sexual or physical abuse. Evidence suggests that these effects are mediated by persistent
hyperactivity of hypothalamic corticotropin-releasing factor (CRF)-containing neurons.
However, these effects are not limited solely to hypothalamic CRF circuits but have also
been observed in limbic areas including the amygdala (30), a brain region shown in imaging
studies to be involved in the pathobiology of depression.
Similar to humans, in bonnet macaques and rhesus monkeys, hypersecretion of CRF, as
evidenced by increased cerebrospinal fluid (CSF) concentration, has been detected years
after the initial period of stress exposure to the mother-infant dyad (31). Similar findings
have been reported in clinical studies where women with a history of child abuse and/or
neglect exhibit hyperactivity of the HPA axis in the Trier Social Stress Test and increased
CSF CRF concentrations. In addition, these patients exhibited decreased CSF concentrations
of oxytocin, a peptide shown to be important in social biology and bonding, increased
inflammatory markers such as interleukin-6 (IL-6), and reduced hippocampal volume as
measured by structural magnetic resonance imaging (32). Genetic polymorphisms of the
CRF receptor 1 and of FK506 binding protein 5, a gene that codes a glucocorticoid receptor
(GR) co-chaperone protein, have recently been implicated in the child abuse-associated
increase in vulnerability to major depression and posttraumatic stress disorder, respectively
(33,34). Interestingly, there is emerging evidence that these genes can also be epigenetically
regulated, thus building support for the long-term consequences of early life experience in
programming disease risk, as recently reported for the promoter methylation of the neuronal
specific GR in suicide victims with a history of childhood abuse, highlighting an effect of
parental care on offspring long-term stress pathway regulation (35). Further supporting a
gene × environment interaction for development of affective disorders is the growing
evidence of a genetic predisposition that underlies a stress-sensitive phenotype, thereby
increasing the likelihood for stress experience throughout life, elevating the risk for disease
(as reviewed in [36]).
Animal Models
Focusing on outcomes from these epidemiological and clinical studies, animal models have
aided in the examination of endophenotypes of neurodevelopmental disorders to identify the
role of early life programming in the alterations of brain structure and function that may
promote disease. The mechanisms by which early life experience, especially stress,
inflammation/infection, and maternal care, are able to program the brain to confer
vulnerability or resilience seem to involve epigenetic modulation of the expression of
individual genes or large gene clusters. Historically, the term epigenetics referred to
heritable traits that are not mediated by changes in DNA sequence. More recently,
epigenetics has been used more broadly to refer to an alteration in gene function not
associated with sequence variation (2). Epigenetic mechanisms involve DNA methylation;
histone modifications, such as acetylation and methylation; and noncoding RNAs, including
microRNAs (see recent reviews on this topic [3–5]). Increasing evidence shows that
numerous types of chromatin modifications, referred to as chromatin remodeling, are
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widespread in the brain and undergo dynamic regulation in both the developing and adult
nervous system (6). Determination of the long-term effect of such reprogramming on
important biological phenomenon can be bidirectional. For instance, longitudinal studies of
squirrel monkey development have shown that early life stress inoculation diminished
subsequent indications of anxiety, increased exploration of novel situations, and decreased
stress levels of cortisol compared with age-matched monkeys raised in undisturbed social
groups (37). Stress inoculation also enhanced prefrontal-dependent cognitive control of
behavior and increased ventromedial prefrontal cortical volumes (38). In rodent models,
augmented maternal care promoted resilience to stress later in life, where rat pups that
received enriched maternal care showed reduced excitatory drive to hypothalamic CRF
neurons resulting from a reduced number of excitatory, glutamatergic synapses on these
cells but without change in gamma-aminobutyric acid (GABA)-ergic innervation (39).
Reduced excitation was associated with a long-term reduction in CRF expression and
respective alterations in binding of the neuron-restrictive silencing factor and, hence,
lowered activation of the HPA stress axis in response to future perturbations. In stark
contrast with such models of stress-mediated resilience, chronic postnatal stress can promote
cognitive decline via functional and structural programming of the hippocampus (40). Such
studies suggest that the magnitude of stress may determine its long-lasting effects such that
modest postnatal stress may promote resilience, whereas severe or chronic stress may set in
motion mechanisms that contribute to stress-related neurodevelopmental disease.
Early life stresses have been broadly associated with disease susceptibility; however, it is
important to recognize that the developing nervous system is likely to show a temporal
specificity in programming of long-term effects. Recent studies in rodent models have
focused on determining the timing of prenatal stress on offspring outcomes including
anhedonia, emotionality, and cognitive deficits related to neurodevelopmental disorders. As
supported by epidemiological findings, early prenatal stress in mice and guinea pigs has
been shown to produce outcomes of increased stress sensitivity in physiological and
behavioral measures in male animals (41,42). Such models have also demonstrated cognitive
deficits in spatial learning and memory tasks, again supporting the specificity to the timing
of the insult with the outcome.
As elevated physiological stress responsivity is a hallmark of many neuropsychiatric
disorders (43), such models focusing on early gestation highlight a specific window in
which genes may be epigenetically reprogrammed to produce long-term changes in stress
pathway development. Adult male mice exposed to early prenatal stress show expression
and DNA methylation changes in CRF and GR (42,44). The temporal specificity reported in
these studies supports early pregnancy as a vulnerable period, and the sex specificity
determined in these animal models may provide insight into male-biased
neurodevelopmental disorders such as autism or schizophrenia. Mechanistically, maternal
glucocorticoids are likely to be involved in transmitting the maternal stress signal to the
developing embryo. Prenatal glucocorticoid overexposure produces long-term changes in
offspring cardiometabolic, neuroendocrine, and behavioral outcomes via tissue-specific
effects on gene promoter epigenetic changes (45). The importance of the endocrine placenta
as the intermediary tissue joining the maternal milieu and the developing embryo must also
be considered to mechanistically define genes and antecedents involved in programming of
neurodevelopmental disorders (as reviewed in [46–48). Studies have also begun to address
transgenerational outcomes attributed to levels of maternal care, diet, stress, or infection to
identify specific genes associated with disease endophenotypes, thereby supporting a true
epigenetic mode of transmission (49).
Rodent models of maternal immune activation have substantiated a role for infections in
offspring disease risk and changes in cognitive and affective behaviors (50–52). Increased
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levels of cytokines such as IL-6 have been associated with deficits of several behaviors and
neurophysiologic functions, including prepulse inhibition and latent inhibition (53). Mice
treated with IL-6 antibodies and IL-6 knockout mice do not manifest these deficits following
maternal infection, supporting a role for inflammation during neurodevelopment in
programming of behavioral deficits that may be endophenotypes of schizophrenia. The
linkage between prenatal immune challenge and behavioral deficits in the offspring related
to schizophrenia may be due to a disruption of GABA and glutamate function in limbic
structures including the prefrontal cortex and hippocampus (54). The temporal specificity
noted in these studies supports an important mechanistic contribution of developmental
timing in determination of the long-term programming effects.
Programming Effects of Maternal Diet and Early Nutrition
Not surprisingly, maternal nutrition alone or in combination with other prenatal
determinants has been identified as a likely factor involved in the programming of offspring
disease risk (55). Recent epidemiological studies from the Dutch Hunger Winter and the
1959 to 1961 Chinese famines have provided convincing evidence that prenatal
undernutrition increases the risk of schizophrenia twofold in adult life (56,57). A variety of
scenarios may explain these outcomes, including epigenetic programming effects related to
levels of nutrients and methyl donors such as choline or folic acid during development
(58,59). Studies have begun to address the issue of epigenetic programming in schizophrenia
risk by examining archived prenatal serum specimens for prospective biomarkers such as
nutrient deficiency that might predict disease susceptibility. Examination of gene
methylation changes associated with prenatal nutrition has revealed that individuals
prenatally exposed to famine during the Dutch Hunger Winter showed reduced DNA
methylation of the imprinted insulin-like growth factor 2 gene 6 decades later compared
with unexposed same-sex siblings (60). This outcome was specific to a periconceptional
exposure supporting the conclusion that very early development is a critical time point in
programming of epigenetic marks that may determine disease risk.
Mechanistic studies using a variety of animal models have dissected the link between the
perinatal nutritional state and the offspring’s metabolic phenotype. As the organization of
neural circuits controlling energy balance take shape during perinatal life, considerable
attention has focused on the hypothalamus. The adipocyte hormone leptin plays a vital role
in directing development of hypothalamic projections from the arcuate nucleus. Moreover,
secretion of leptin during perinatal life changes in response to the nutritional environment
and thus is poised to signal the developing brain regarding maternal overnutrition or
undernutrition via distinct actions on two functionally divergent neuronal populations, the
anorexigenic pro-opiomelanocortin and orexigenic neuropeptide Y neurons (61). Targets of
these neurons, such as the paraventricular nucleus and lateral hypothalamus, contain several
cell types that exert widespread regulatory actions on energy balance and are likely impacted
by numerous hormonal and neurotrophic factors yet to be defined. Such studies have
perhaps identified specific modes of neurodevelopmental programming whereby the wiring
of the hypothalamus is determined through endocrine signals (62).
Equally intriguing is the possibility that perinatal nutritional cues influence growth,
independent of adiposity, through central mechanisms that influence body length or height
via epigenetic modifications of specific genes during early development (63). Maternal
exposure to a high-fat diet in mice results in both significant body length increases and
reduced insulin sensitivity that persist across at least two generations. The acquisition of this
phenotype in the second generation is not attributable to altered intrauterine conditions or
maternal feeding behavior, as both maternal and paternal lineages pass on the effect to the
second generation, supporting a germline-based epigenetic manner of inheritance. Similarly,
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a maternal low-protein diet affects offspring growth and food intake and recently was shown
to disrupt the expression of dopamine-related molecules within the mesocorticolimbic
circuitry and a number of dopamine-dependent reward-related behaviors (64,65). Epigenetic
modification (DNA hypomethylation) and subsequent effects on target genes
(overexpression) are potential mechanisms linking suboptimal prenatal environment and
adverse behavioral outcome.
Epigenetic mechanisms that exert lasting effects on gene expression and can be heritable are
a particularly intriguing target when examining links between the perinatal nutritional
environment and offspring metabolic phenotype. For example, foods high in choline cause
marked changes in DNA methylation, which, in turn, alter long-term gene expression.
Choline deficiency induced during gestation produced alterations in histone methylation and
subsequent changes in gene expression in mice (66). Pregnant dams fed choline-deficient
diets during late gestation produced offspring with diminished progenitor cell proliferation
and increased fetal hippocampus apoptosis, altered hippocampal angiogenesis, insensitivity
to long-term potentiation as adults, and decremented visual-spatial and auditory memory.
These changes in fetal brain development appeared to be mediated by epigenetic alterations
such as maternal dietary choline-modulated DNA and histone methylation in the fetal
hippocampus. Similarly, studies using changes in mouse coat color as a marker of dietary
and nutrient influence on epigenetic regulation of the agouti locus document how relatively
minor methylation changes can have a profound impact on gene expression (67).
Further mechanistic examination of maternal nutritional state effects on programming of
offspring health has been modeled in paradigms including placental insufficiency and
hypoxia. Using uterine artery ligation to model intrauterine growth retardation and examine
offspring diabetes development, studies have highlighted specific alterations in histone
acetylation, decreasing the expression of genes including pancreatic duodenal homeobox 1,
a growth factor critical in pancreatic development (68–70). Recent observations suggesting
that hormone receptor signaling pathways and genes that control expression of neurotrophic
factors can be epigenetically regulated point to a promising avenue of future research.
What Does Sex Have to Do with It?
One area of emphasis that has not been well examined or discussed in early life
programming is that of the role or involvement of sex in disease vulnerability, presentation,
and outcome. Why do some neurodevelopmental disorders predominate in male subjects and
others in female subjects? Numerous neurodevelopmental diseases exhibit such a sex bias:
for example, women present with affective disorders at two to three times the rate of men,
autism affects four times as many boys as girls, and the onset of schizophrenia and
depression rises dramatically during adolescence when major sex differences in brain
maturation occur (19). Therefore, elucidation of the mechanisms by which sex-specific
susceptibility arises is likely to provide critical insight into disease etiology, leading to the
identification of novel targets for therapeutic development across disease areas that are
affected by a gene × environment influence. Although there are many factors that likely
contribute to sex differences in disease predisposition, sex-specific responses to fetal
antecedents occurring during sensitive windows of development may promote long-term
programming effects that underlie such disease biases (71). Along these lines, structural
brain volume analyses using magnetic resonance imaging in male and female patients with
schizophrenia have confirmed a disruption of the normal sexual dimorphism of the brain
(72), including the dimorphic ratio of orbitofrontal cortex to amygdala where male
schizophrenic patients showed a feminization of these brain regions (73). Interestingly, the
neurodevelopmental disorders schizophrenia and autism have been categorized as
hypomasculinized and hypermasculinized, respectively, supporting potential involvement of
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perturbations in the normal trajectory and maturation of the sexually dimorphic brain in
disease etiology.
The developing brain is characterized by the combined and opposing forces of resiliency and
vulnerability. The central factors important in resilience, ongoing neurogenesis, migration,
myelination, differentiation, and synaptogenesis are the same processes subject to
derailment, which can have enduring and devastating consequences. The complex interplay
of genetics, early experience, and later environment underlies the weak but consistent
heritability of numerous neurodevelopmental disorders. The developing brain is organized
by developmental hormone exposure, with male subjects experiencing elevated androgens
that drive masculinization, an active process affecting cell differentiation and connectivity.
Estrogenic involvement in cell death and cell birth in the developing nervous system is a
critical component in programming the sexually dimorphic brain (74,75). Recent evidence
implicates epigenetic changes in the estrogen receptor gene promoter as a component of the
lasting effects of developmental estradiol action (76). The variety of mechanisms evoked by
estradiol provides numerous avenues for disruption of the active process of masculinization,
which may contribute to the sex bias found in many neurodevelopmental disorders.
Programming of important regulatory brain regions such as the hypothalamus via steroid
hormone effects on cell migration patterns during early development may also contribute to
sex differences in disease susceptibility (77).
Epigenetic Mechanisms for Stable Behavioral Modification
Studies in adult animal models have used molecular and pharmacological methodologies to
identify potential genes and mechanisms involved in disease programming. For example,
histone deacetylase (HDAC) inhibitors, which are thought to promote gene transcription,
produce antidepressant-like effects in rodent models of chronic stress such as social defeat
(78). Chronic exposure of inbred mice to social defeat stress induces long-lasting behavioral
abnormalities that are reminiscent of depression and posttraumatic stress disorder and can be
treated effectively with standard antidepressant medications. Interestingly, roughly one third
of the inbred mice exposed to chronic social defeat stress are resilient to its deleterious
consequences. Insight into the molecular basis of vulnerability versus resiliency and the
reversal of symptoms in vulnerable animals with antidepressants has come from gene
expression microarrays and chromatin immunoprecipitation-on-chip arrays, which
respectively permit genome wide assessments of alterations in messenger RNAs and in
chromatin modifications within brain regions of interest (78,79). These data illustrate that
resilience is an active process, mediated by changes in gene expression and chromatin
modifications unique to the resilient state. Moreover, they have revealed important overlap
between the mechanisms of resilience and of antidepressant action, suggesting that
antidepressants may work, in part, by inducing changes in gene expression that occur
naturally in more resilient individuals. Such findings provide new avenues for the
development of more effective antidepressant treatments.
In addition to being potential targets as antidepressants, HDACs have recently been
identified as important regulators of the developmental switch controlling synapse
maturation. Both histone deacetylase 1 and histone deacetylase 2 function during early
synaptic development causing a robust facilitation of excitatory synapses with a modest
increase in synapse numbers (80). Interestingly, these studies found that in adults, a decrease
in histone deacetylase 2 levels alone was sufficient to decrease basal excitatory
neurotransmission. These findings provide important information on an underlying intrinsic
developmentally specific pathway and suggest that HDAC inhibitors as therapeutics may
have vastly different outcomes during development than they would in the adult.
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Conclusions
At the crossroads of the developing brain and the perturbations poised to promote any
deviation from this norm may lay the programming events contributing to disease
susceptibility or resistance. Studies aimed at this level afford us a great opportunity to define
disease mechanisms and identify novel targets in therapy and prevention. The interaction of
the clinical, epidemiological, and basic science communities is essential in evaluation of
study outcomes and in defining future directions and needs. New mechanisms and models
developed at the bench will inform clinicians as to potential markers and targets to be
examined at the bedside, with novel clinical observations then characterized for underlying
mechanisms in animal models. Highly innovative tools and techniques are continuously
being developed with greater and greater depths of analyses that will, no doubt, in the near
future identify an array of novel genes and epigenetic mechanisms involved in the
development of neuropsychiatric diseases. It is crucial that as this fast-moving field
progresses, conversations at all levels and across disease areas continue and forums for such
dialogue continue to be encouraged and supported.
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